Upregulation of vimentin has been reported in prostate cancer, lung cancer and carcinosarcoma and vimentin have been used as a marker for lung cancer detection (Liu et al, 2004; Wu et al, 2007; Pardo et al, 2008; Wei et al, 2008). This evidence concerns the gene VIM and carcinosarcoma.